ScholarIQanswers from OpenAlex

Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway

PaperCitations, authors & open-access status

Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway have?

ScholarIQcitation count

Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has 6 citations in the OpenAlex counts ScholarIQ stores.

When was Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway published?

ScholarIQyear

Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has 2025 year in the ScholarIQ index.

What is the open-access status of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?

ScholarIQoa status

Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway has gold oa status in the ScholarIQ index.

What is the DOI of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?

ScholarIQdoi

The DOI for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.

What is the PMID of Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?

ScholarIQpmid

The PMID for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.

What is the OpenAlex record for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway?

ScholarIQopenalex

The OpenAlex for Remifentanil Ameliorates Lipopolysaccharide‐Induced Neuroinflammation by Regulating the Phosphatidylinositol 3‐Kinase/Serine–Threonine Protein Kinase/Hypoxia‐Inducible Factor 1 Alpha Pathway is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial